— Know what they know.
Not Investment Advice

LGVN NASDAQ

Longeveron Inc.
1W: -8.2% 1M: -62.0% 3M: -60.2% YTD: -56.5% 1Y: -65.2% 3Y: -98.9% 5Y: -99.3%
$2.58
-0.01 (-0.39%)
 
Weekly Expected Move ±32.2%
$1 $2 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 23 · $7.9M mcap · 2M float · 2.89% daily turnover · Short 46% of daily vol

Balance Sheet Trends

Total Assets
$10M -59.9% ▼
5Y CAGR: +2.1%
Total Liabilities
$5M +24.9% ▲
5Y CAGR: -8.8%
Shareholders Equity
$6M -74.1% ▼
5Y CAGR: +23.7%
Cash & Investments
$5M -75.8% ▼
5Y CAGR: +41.7%
Total Debt
$824K -43.1% ▼
5Y CAGR: -27.6%
Net Debt
-$4M +78.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$26M$11M$5M$19M$5M
Short-Term Investments$9M$9M$412K$0$0
Cash & ST Investments$35M$20M$5M$19M$5M
Net Receivables$55K$218K$111K$84K$104K
Inventory$0$0$0$0$0
Other Current Assets$0$404K$376K$308K$686K
Total Current Assets$35M$20M$6M$20M$5M
Property, Plant & Equip.$5M$4M$4M$3M$2M
Goodwill & Intangibles$2M$2M$2M$2M$2M
Long-Term Investments$0$0$0$0$100K
Other Non-Current Assets$177K$244K$193K$202K$76K
Total Non-Current Assets$7M$7M$6M$6M$5M
Total Assets$43M$27M$12M$26M$10M
— Liabilities —
Accounts Payable$645K$2M$638K$99K$423K
Short-Term Debt$0$0$0$0$655K
Deferred Revenue$199K$506K$506K$40K$40K
Other Current Liabilities$0$1M$0$0$3M
Total Current Liabilities$3M$5M$4M$3M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$265K$330K
Total Non-Current Liabilities$3M$2M$1M$1M$499K
Total Liabilities$5M$7M$5M$4M$5M
— Equity —
Common Stock$21K$21K$2K$14K$22K
Retained Earnings-$44M-$63M-$85M-$110M-$132M
Accumulated OCI$0-$357K$0$0$0
Total Stockholders Equity$37M$21M$7M$22M$6M
Total Liabilities & Equity$43M$27M$12M$26M$10M
— Key Metrics —
Total Debt$3M$3M$2M$1M$824K
Net Debt-$23M-$8M-$3M-$18M-$4M
Total Investments$9M$9M$412K$0$100K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms